A Systematic Review of Nonclinical Studies on the Effect of Curcumin in Chemotherapy- induced Cardiotoxicity
- PMID: 35570565
- DOI: 10.2174/1381612828666220513125312
A Systematic Review of Nonclinical Studies on the Effect of Curcumin in Chemotherapy- induced Cardiotoxicity
Abstract
Background: Various anticancer drugs are effective therapeutic agents for cancer treatment; however, they cause severe toxicity in body organs. Cardiotoxicity is one of the most critical side effects of these drugs. Based on various findings, turmeric extract has positive effects on cardiac cells.
Objective: This study aims to evaluate how curcumin, as the main component of turmeric, may affect chemotherapy- induced cardiotoxicity.
Methods: A database search was performed up to April 2021 using "curcumin OR turmeric OR Curcuma longa" and "chemotherapy-induced cardiac disease", including their equivalents and similar terms. After screening the total articles obtained from the electronic databases, 25 relevant articles were included in this systematic review.
Results: The studies demonstrate lower body weight and increased mortality rates due to doxorubicin administration. Besides, cancer therapeutic agents induced various morphological and biochemical abnormalities compared to the non-treated groups. Based on most of the obtained results, curcumin at nontoxic doses can protect the cardiac cells mainly through modulating antioxidant capacity, regulation of cell death, and antiinflammatory effects. Nevertheless, according to a minority of findings, curcumin increases the susceptibility of the rat cardiomyoblast cell line (H9C2) to apoptosis triggered by doxorubicin.
Conclusion: According to most nonclinical studies, curcumin could potentially have cardioprotective effects against chemotherapy-induced cardiotoxicity. However, based on limited, contradictory findings demonstrating the function of curcumin in potentiating doxorubicin-induced cardiotoxicity, well-designed studies are needed to evaluate the safety and effectiveness of treatment with new formulations of this compound during cancer therapy.
Keywords: Curcumin; cardiotoxicity; chemotherapy; cyclophosphamide; doxorubicin; irinotecan; turmeric extract.
Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.
Similar articles
-
Assessment of herb-drug synergy to combat doxorubicin induced cardiotoxicity.Life Sci. 2018 Jul 15;205:97-106. doi: 10.1016/j.lfs.2018.05.021. Epub 2018 May 9. Life Sci. 2018. PMID: 29752960
-
Mode of treatment governs curcumin response on doxorubicin-induced toxicity in cardiomyoblasts.Mol Cell Biochem. 2018 May;442(1-2):81-96. doi: 10.1007/s11010-017-3195-6. Epub 2017 Sep 19. Mol Cell Biochem. 2018. PMID: 28929270
-
In Vitro and In Vivo Cardioprotective Effects of Curcumin against Doxorubicin-Induced Cardiotoxicity: A Systematic Review.J Oncol. 2022 Feb 21;2022:7277562. doi: 10.1155/2022/7277562. eCollection 2022. J Oncol. 2022. PMID: 35237323 Free PMC article. Review.
-
Curcumin potentiates doxorubicin-induced apoptosis in H9c2 cardiac muscle cells through generation of reactive oxygen species.Food Chem Toxicol. 2011 May;49(5):1102-9. doi: 10.1016/j.fct.2011.01.021. Epub 2011 Feb 2. Food Chem Toxicol. 2011. PMID: 21295102
-
Turmeric (Curcuma longa) and its major constituent (curcumin) as nontoxic and safe substances: Review.Phytother Res. 2018 Jun;32(6):985-995. doi: 10.1002/ptr.6054. Epub 2018 Feb 26. Phytother Res. 2018. PMID: 29480523 Review.
Cited by
-
Unveiling the therapeutic potential of cabozantinib-loaded poly D,L-lactic-co-glycolic acid and polysarcosine nanoparticles in inducing apoptosis and cytotoxicity in human HepG2 hepatocellular carcinoma cell lines and in vivo anti-tumor activity in SCID female mice.Front Oncol. 2023 Feb 15;13:1125857. doi: 10.3389/fonc.2023.1125857. eCollection 2023. Front Oncol. 2023. PMID: 36874145 Free PMC article.
-
A review of chemotherapeutic drugs-induced arrhythmia and potential intervention with traditional Chinese medicines.Front Pharmacol. 2024 Mar 20;15:1340855. doi: 10.3389/fphar.2024.1340855. eCollection 2024. Front Pharmacol. 2024. PMID: 38572424 Free PMC article. Review.
-
Enhancing the Bioavailability and Bioactivity of Curcumin for Disease Prevention and Treatment.Antioxidants (Basel). 2024 Mar 8;13(3):331. doi: 10.3390/antiox13030331. Antioxidants (Basel). 2024. PMID: 38539864 Free PMC article. Review.
-
What can traditional Chinese medicine do for adult neurogenesis?Front Neurosci. 2023 Apr 12;17:1158228. doi: 10.3389/fnins.2023.1158228. eCollection 2023. Front Neurosci. 2023. PMID: 37123359 Free PMC article. Review.
-
From bench to bedside: exploring curcumin-driven signaling pathways in immune cells for cancer management.Inflammopharmacology. 2025 May;33(5):2293-2306. doi: 10.1007/s10787-025-01739-5. Epub 2025 Apr 17. Inflammopharmacology. 2025. PMID: 40244492 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous